Treatment of Diabetes After Gastric Bypass With Sitagliptin (LAF33)

This study is currently recruiting participants. (see Contacts and Locations)
Verified May 2016 by Columbia University
Sponsor:
Collaborator:
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Blandine Laferrere, Columbia University
ClinicalTrials.gov Identifier:
NCT01512797
First received: January 13, 2012
Last updated: May 10, 2016
Last verified: May 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2016
  Estimated Primary Completion Date: August 2016 (Final data collection date for primary outcome measure)